XeUS Technologies (Cyprus)

Xeus Technologies Ltd established in 2016 is focused on biomedical technologies specialized in Gaseous Hyperpolarized Xenon-129 and parahydrogen production technology used as NMR and MRI contrast agents. Xeus Technologies also offers supporting instrumentation which enable experimentation using techniques such as PHIP, SABRE, Xenon HyperCEST, etc.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about XeUS Technologies (Cyprus).

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Xeus Technologies Ltd established in 2016 is focused on biomedical technologies specialized in Gaseous Hyperpolarized Xenon-129 and parahydrogen production technology used as NMR and MRI contrast agents. Xeus Technologies also offers supporting instrumentation which enable experimentation using techniques such as PHIP, SABRE, Xenon HyperCEST, etc.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.